产品编号 | CFN95300 | |
CAS编号 | 81474-89-7 | |
分子式 = 分子量 | C41H62O15 = 794.9 | |
产品纯度 | >=98% | |
物理属性 | Powder | |
化合物类型 | Steroids | |
植物来源 | The roots of Cynanchum stauntonii | |
ChemFaces的产品在影响因子大于5的优秀和顶级科学期刊中被引用 |
产品名称 | 产品编号 | CAS编号 | 包装 | QQ客服 |
白前苷C | CFN95300 | 81474-89-7 | 1mg | QQ客服:1413575084 |
白前苷C | CFN95300 | 81474-89-7 | 5mg | QQ客服:1413575084 |
白前苷C | CFN95300 | 81474-89-7 | 10mg | QQ客服:1413575084 |
白前苷C | CFN95300 | 81474-89-7 | 20mg | QQ客服:1413575084 |
Description: | Anticancer. Glaucoside C was evaluated against the HT-29 and HCT 116 human colon cancer cell lines. | |||
In vitro: |
|
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 1.258 mL | 6.2901 mL | 12.5802 mL | 25.1604 mL | 31.4505 mL |
5 mM | 0.2516 mL | 1.258 mL | 2.516 mL | 5.0321 mL | 6.2901 mL |
10 mM | 0.1258 mL | 0.629 mL | 1.258 mL | 2.516 mL | 3.145 mL |
50 mM | 0.0252 mL | 0.1258 mL | 0.2516 mL | 0.5032 mL | 0.629 mL |
100 mM | 0.0126 mL | 0.0629 mL | 0.1258 mL | 0.2516 mL | 0.3145 mL |
产品名称 | 产品编号 | CAS编号 | 分子式 = 分子量 | 位单 | 联系QQ |
通关藤苷G; Tenacissoside G | CFN97795 | 191729-43-8 | C42H64O14 = 792.96 | 20mg | QQ客服:2056216494 |
通关藤苷I; Tenacissoside I | CFN97794 | 191729-44-9 | C44H62O14 = 814.97 | 20mg | QQ客服:2056216494 |
苦绳苷D; Dregeoside Da1 | CFN97890 | 98665-65-7 | C42H70O15 = 815.0 | 5mg | QQ客服:2056216494 |
苦绳甙Ga1; Dregeoside Ga1 | CFN97588 | 98665-66-8 | C49H80O17 = 941.17 | 5mg | QQ客服:2056216494 |
苦绳甙Aa1; Dregeoside Aa1 | CFN97790 | 20230-41-5 | C49H78O17 = 939.15 | 5mg | QQ客服:1413575084 |
青阳参苷F ; Otophylloside F | CFN89258 | 250217-73-3 | C48H76O16 = 909.11 | 5mg | QQ客服:1457312923 |
青阳参苷B; Otophylloside B | CFN96964 | 106758-54-7 | C49H78O16 = 923.13 | 5mg | QQ客服:2056216494 |
青阳参苷元A; Qingyangshengenin A | CFN80437 | 106644-33-1 | C49H72O17 = 933.09 | 5mg | QQ客服:1457312923 |
苦绳苷A11; Dregeoside A11 | CFN96087 | 89020-11-1 | C55H88O22 = 1101.3 | 5mg | QQ客服:2056216494 |
Otophylloside B 4'''-O-alpha-L-cymaropyranoside; Otophylloside B 4'''-O-alpha-L-cymaropyranoside | CFN89225 | 171422-82-5 | C56H90O19 = 1067.31 | 5mg | QQ客服:215959384 |